Video: Superheroes, Secret Identities & You| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

EULAR/Other

EULAR 2014: Non-Tumor Necrosis Factor Biologics Update

Thomas R. Collins  |  August 1, 2014

Clinical trials on rheumatology drugs, including sarilumab, show promise for patients with rheumatoid arthritis also taking methotrexate

EULAR 2014: Biosimilar Drug Production Raises Concerns

Thomas R. Collins  |  August 1, 2014

Rheumatology experts question biosimilars’ safety, efficacy given their complex production process

EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis

Thomas R. Collins  |  August 1, 2014

Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA

Lupus Classification Criteria Expanded; Treat-to-Target Approach Gains Support

Gretchen Henkel  |  July 1, 2014

Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco outline disease classification criteria, treat-to-target approach to lupus

Rheumatologist Marc C. Hochberg, MD, MPH, Advances Epidemiology Through Collaborative Ties

Gretchen Henkel  |  May 1, 2014

Accomplished physician noted for research in gout, osteoarthritis etiology; characterizing therapeutic responsiveness in disease states; inspiring teamwork among rheumatologists

ACR Board of Directors Tackles Slate of Business at Annual Meeting

Staff  |  April 2, 2014

Board welcomes 233 new and returning candidates, lends support to lupus classification criteria in partnership with EULAR, approves update of ACR policy statements and position statements at February meeting in Napa, Calif.

President’s Perspective: The ACR and ARHP Advance Rheumatology Through International Collaboration

Audrey B. Uknis, MD, and Jan K. Richardson, PT, PhD, OCS  |  August 1, 2013

By forging new connections and strengthening efforts with global organizations such as EULAR, the College hopes to enhance the science, clinical care, and perceived value of rheumatology

Studies Show Promise for Scleroderma Therapy and Prediction of Progressing Disease

Thomas R. Collins  |  October 1, 2012

Research shows that a serum from goats might be helpful in combating diffuse cutaneous systemic sclerosis (SSc)

EULAR: Identify Arthritis Early, Treat it Effectively

Thomas R. Collins  |  October 1, 2012

Recent studies are uncovering genetic and environmental factors at play in the earliest stages of rheumatoid arthritis and medications that are effective in treating juvenile idiopathic arthritis

EULAR 2012: MicroRNAs’ Role in Rheumatic Diseases Coming into Sharper Focus

Thomas R. Collins  |  September 5, 2012

MicroRNAs are poised to play a big role in the future understanding and treatment of rheumatoid arthritis.

  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences